Coya Therapeutics (COYA) News
NASDAQ: COYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.95-0.03 (-1.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COYA news summary
We found 2 recent headlines mentioning Coya Therapeutics (COYA): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, Business Wire. For price context, COYA is down 1.01% at $2.95. The most recent story, "Coya Therapeutics Reports Wider Q3 Loss; Expects Phase 2/3 ALSTARS ALS Data In Q2 2027", was published by Nasdaq on Nov 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Coya Therapeutics headlines
- Coya Therapeutics Reports Wider Q3 Loss; Expects Phase 2/3 ALSTARS ALS Data In Q2 2027(RTTNews) - Coya Therapeutics, Inc. (COYA), a clinical-stage biotechnology company developing biologics for neurodegenerative disorders, announced its financial results for the third quarter ended…NasdaqCOYA, HEI.A
- Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate UpdateHOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in…Business Wire